(PharmaNewsWire.Com, May 23, 2017 ) Asia-Pacific Colorectal Cancer Market research report, published by Market Data Forecast estimates that the market is growing with a CAGR of 3.40% to reach USD 4.89 billion by 2021, from USD 4.14 billion in 2016, which amounts to a cumulative growth of USD 0.75 billion.
Colorectal cancer is a kind of cancer where cells are developed in rectum. Cancer refers to uncontrollable growth of cells which have the capability of spreading to others parts of the body.
To give an idea depth, the symptoms of colorectal cancer are bowel movement changes, weight loss, blood found in the stool and frequent tired feeling. This is mostly occurred in people at old age or any other genetic disorder. It can be diagnosed by taking colon sample during colonoscopy then it is followed by medical imaging. Medical imaging is the method of making a visual image of the inside of the body for medical intervention. These devices aid in creating a databank of normal anatomy and physiology of internal organs so that any irregularity can be observed immediately. Internationally, most of the industrialized nations are spending a huge part of their GDP on healthcare necessities.
The report also presents detailed analysis of multitude of factors affecting the diagnostic imaging market bearing either positive or negative outcomes. Some of those factors are • Increasing awareness about Colorectal diseases, • Availability of modern therapies in the market, • Increasing prevalence of colorectal cancer, • Improving healthcare infrastructure in developing markets, • High cost of the cancer treatments, • Side effects of the treatment, • High cancer drugs toxicity.
For granular level understanding the Colorectal Cancer Market is segmented based on diagnostic and treatment, each being provided with Market Size Estimations and Y-o-Y Forecasts.
Based on Diagnostic the market is segmented as Digital Rectal Examination, Faecal Occult Blood Test, Flexible Sigmoidoscopy, Colonoscopy, Virtual Colonoscopy. Based on Application it is further segmented into Surgery and Radiation Therapy, Chemotherapy, Targeted Therapies, Resistance to Pharmacological Therapies.
India and China are the major economies which have unexplored customer base covered in the study. The report also focuses on other regions like Japan, Australia, South Korea and Rest of Asia-Pacific. China and India are estimated to be the fastest growing in terms of CAGR thereby, leading to further growth of Asia-Pacific Colorectal Cancer Market.
Some of the key players that operate in the Asia-Pacific Colorectal Cancer market include Abbott Diagnostics, Alere, Beckman Coulter, Clinical Genomics, Companion Dx, Hoffmann La Roche, Debiopharm Group and Vaccinogen BD. Due to technological advancements and improvement of healthcare facilities there is an increase in the competition among key players.
The Asia- Pacific Colorectal Cancer market report offers wide-range of scope:
• Regional and country-level analysis that provides an individual perspective of Asia-Pacific region and the aforementioned countries • Know more about key areas of industry growth via detailed Segment-level analysis on basis of diagnostic, treatment, along with market size forecasts and y-o-y estimations
• Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics
• Strategic Analyses containing PESTLE and Porter’s Five Forces Analyses which are obtained by studying the macro & micro environmental factors that affect the market demographics
• Comprehensive listing of key market players along with Company overview, product portfolios, financials (subjected to availability), SWOT analysis and analyst overview
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
• Market Outlook - Investment opportunities devised by stand in experts to provide both individuals and organizations a strong financial foothold in the market
For more reports related to the Therapeutics Market:
About us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
